Filing Details
- Accession Number:
- 0001181431-12-058977
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-11-16 13:16:37
- Reporting Period:
- 2012-11-14
- Filing Date:
- 2012-11-16
- Accepted Time:
- 2012-11-16 13:16:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1369786 | Sagent Pharmaceuticals Inc. | SGNT | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1518010 | Michael Logerfo | C/O Sagent Pharmaceuticals, Inc. 1901 North Roselle Road, Suite 700 Schaumburg IL 60195 | Chief Legal Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-11-14 | 1,800 | $4.23 | 15,415 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-11-14 | 1,000 | $14.56 | 14,415 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2012-11-15 | 17,338 | $4.23 | 31,753 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-11-15 | 9,000 | $14.38 | 22,753 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option to Buy | Disposition | 2012-11-14 | 1,800 | $0.00 | 1,800 | $4.23 |
| Common Stock | Stock Option to Buy | Disposition | 2012-11-15 | 17,338 | $0.00 | 17,338 | $4.23 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 17,338 | 2018-08-15 | No | 4 | M | Direct | |
| 0 | 2018-08-15 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 1,000 | Indirect | See Footnote |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.50 to $14.71, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.25 to $14.71, inclusive.
- Shares held by a member of Mr. Logerfo's immediate family sharing the same household. Mr. Logerfo disclaims beneficial ownership of such shares.
- Stock option granted on August 15, 2008 and vests upon the achievement of certain milestones.
- Stock option granted on August 15, 2008 and vests upon the achievement of certain milestones.
Billionaire Hedge Funds
